By: Annette McElhiney
Before I had cancer, I was strong, confident, and secure. While it was not always that way, it took years of education, exposure in the classroom and at professional conferences for me to feel good about myself. … Read more
Most women diagnosed with ovarian cancer undergo surgery to remove as many of the tumors as possible. However, it is usually impossible to eliminate all of the cancer cells because they have spread throughout the abdomen. Surgery is therefore followed … Read more
By: Marcella Lee, CBS 8 Anchor/Reporter
A local non-profit is working to improve ovarian cancer survival rates by guiding patients into a new frontier.
Ovarian cancer is known as a silent killer because symptoms are vague like: bloating, abdominal or … Read more
Latest results from a mid-stage trial of ImmunoGen Inc’s experimental antibody-drug conjugate show that it shrinks or stabilizes tumors in nearly half of advanced ovarian cancer patients with at least medium levels of a key biomarker whose disease has become … Read more
One in four women with ovarian cancer develop blood clots, and over 10% develop clots during neoadjuvant chemotherapy given before surgery, according to a study published online May 5 in Obstetrics & Gynecology.
Past efforts at preventing blood clots in … Read more
In the treatment of advanced ovarian cancer, PARP inhibitors, including olaparib (Lynparza), rucaparib (Rubraca), and niraparib (Zejula), are stealing the limelight, explains Dennis Scribner, MD.
In an interview with Targeted Oncology, Scribner, a gynecologic oncologist at Arizona Oncology, discussed … Read more
Targeting the immune system to fight cancer is not new: in 1891, New York bone sarcoma surgeon William B. Coley injected a patient with an inoperable malignant tumor with streptococcal organisms. His theory was that the resulting severe bacterial infection, … Read more
Johnson & Johnson was ordered by a St. Louis jury to pay more than $110 million to a Virginia woman who blamed her ovarian cancer on the company’s talcum products.
Imerys Talc America, which provided the talc to J&J, was … Read more
Adding bevacizumab to platinum-based chemotherapy may improve survival among women with recurrent ovarian cancer, according to a study published in Lancet Oncology.1
Bevacizumab is emerging as an effective strategy as a first-line or maintenance therapy for recurrent ovarian … Read more
Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer — the most common subtype of ovarian cancer — after standard treatment with the chemotherapy drug carboplatin.
Preclinical research from … Read more
Teri Woodhull is decidedly proactive. A strong family history of breast cancer led her to undergo a preventive bilateral mastectomy at age 30. Seventeen years later, she was diagnosed with stage 3b high-grade serous epithelial ovarian cancer.
“I do have … Read more
By: Susan Gubar
Six days after an unremarkable lumpectomy, I had rushed to the local hospital, not so much because of pain but out of concern. I had been eating and drinking as usual, but what was going in was … Read more
By: Annette McElhiney
One
Facing cancer makes you think about things you’ve never have before. It makes you feel things you wish you’d never have to. It forces you to change. Suddenly you find yourself a member of an unfamiliar … Read more
Myriad Genetics had been exclusively providing tests, for $3000+ a pop for full BRCA gene sequencing, for 17 years before the Supreme Court invalidated key gene patents back in 2013. Since the ruling a dozen or so competitors have been … Read more
A large hereditary cancer study supports National Comprehensive Cancer Network guidance to consider risk-reducing salpingo-oophorectomy (RRSO) between ages 45 and 50 years for women with BRIP1, RAD51C, or RAD51D mutations, Lydia Usha, MD, said at the annual meeting of the … Read more
UConn Health is beginning to recruit patients for the world’s first personalized genomics-driven ovarian cancer vaccine clinical trial. The goal: to prevent an often deadly relapse of the disease in women diagnosed at advanced stages.
The pioneering injectable vaccine OncoImmunome … Read more
Hypertension, or high blood pressure, may come with a plus side, at least for a subset of women with ovarian cancer. New research from epidemiologists at Roswell Park Cancer Institute, published in the journal Cancer Causes & Control, provides evidence … Read more
The ovarian cancer treatment paradigm underwent another transformation near the end of 2016 with the FDA approval of the PARP inhibitor rucaparib (Rubraca) for patients with BRCA-positive advanced ovarian cancer who have received at least 2 prior lines of … Read more
In her recent book, Reading & Writing Cancer: How Words Heal, Susan Gubar explores the various ways reading and writing about cancer can be a valuable, often therapeutic, tool for patients with cancer. Whether it’s writing a memoir, engaging … Read more
When a cancer diagnosis is given, many challenges arise for patients and their families or caregivers. One of the many challenges is role reversal. Men who have a partner who is diagnosed with cancer may have a change in their … Read more
